EP4065624A1 - Water-based hydrogel, and reaction product of isosorbide epoxide and amines - Google Patents
Water-based hydrogel, and reaction product of isosorbide epoxide and aminesInfo
- Publication number
- EP4065624A1 EP4065624A1 EP20824305.5A EP20824305A EP4065624A1 EP 4065624 A1 EP4065624 A1 EP 4065624A1 EP 20824305 A EP20824305 A EP 20824305A EP 4065624 A1 EP4065624 A1 EP 4065624A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- water
- hydrogel
- soluble
- isosorbide
- epoxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 76
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 47
- 229960002479 isosorbide Drugs 0.000 title claims abstract description 37
- -1 isosorbide epoxide Chemical class 0.000 title claims abstract description 23
- 150000001412 amines Chemical class 0.000 title claims abstract description 18
- 239000007795 chemical reaction product Substances 0.000 title claims abstract description 7
- 229920000642 polymer Polymers 0.000 claims abstract description 14
- 239000000178 monomer Substances 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims description 22
- KLDXJTOLSGUMSJ-JGWLITMVSA-N Isosorbide Chemical compound O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 KLDXJTOLSGUMSJ-JGWLITMVSA-N 0.000 claims description 15
- 239000000047 product Substances 0.000 claims description 14
- 239000002537 cosmetic Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 238000005516 engineering process Methods 0.000 claims description 7
- 230000003287 optical effect Effects 0.000 claims description 7
- 238000000926 separation method Methods 0.000 claims description 7
- 229920000768 polyamine Polymers 0.000 claims description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 5
- 239000004472 Lysine Substances 0.000 claims description 5
- 150000002118 epoxides Chemical class 0.000 claims description 4
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 claims description 4
- 230000036571 hydration Effects 0.000 claims description 3
- 238000006703 hydration reaction Methods 0.000 claims description 3
- XVBLEUZLLURXTF-UHFFFAOYSA-N 2,4-dimethylbenzene-1,3-diamine Chemical compound CC1=CC=C(N)C(C)=C1N XVBLEUZLLURXTF-UHFFFAOYSA-N 0.000 claims description 2
- RNLHGQLZWXBQNY-UHFFFAOYSA-N 3-(aminomethyl)-3,5,5-trimethylcyclohexan-1-amine Chemical compound CC1(C)CC(N)CC(C)(CN)C1 RNLHGQLZWXBQNY-UHFFFAOYSA-N 0.000 claims description 2
- 239000004475 Arginine Substances 0.000 claims description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 2
- MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- 229960001230 asparagine Drugs 0.000 claims description 2
- 235000009582 asparagine Nutrition 0.000 claims description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 2
- 230000001747 exhibiting effect Effects 0.000 claims 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 12
- 239000004480 active ingredient Substances 0.000 description 14
- 239000004593 Epoxy Substances 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000013543 active substance Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229920003169 water-soluble polymer Polymers 0.000 description 4
- 125000003700 epoxy group Chemical group 0.000 description 3
- 229920000647 polyepoxide Polymers 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 229920001187 thermosetting polymer Polymers 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 235000014755 Eruca sativa Nutrition 0.000 description 2
- 241001149093 Eruca vesicaria subsp. sativa Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 235000000183 arugula Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- ZSQBOIUCEISYSW-GKHCUFPYSA-N Methyl alpha-D-glucofuranoside Chemical compound CO[C@H]1O[C@H]([C@H](O)CO)[C@H](O)[C@H]1O ZSQBOIUCEISYSW-GKHCUFPYSA-N 0.000 description 1
- XCOBLONWWXQEBS-KPKJPENVSA-N N,O-bis(trimethylsilyl)trifluoroacetamide Chemical compound C[Si](C)(C)O\C(C(F)(F)F)=N\[Si](C)(C)C XCOBLONWWXQEBS-KPKJPENVSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 239000000227 bioadhesive Substances 0.000 description 1
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920001746 electroactive polymer Polymers 0.000 description 1
- 239000000598 endocrine disruptor Substances 0.000 description 1
- 231100000049 endocrine disruptor Toxicity 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000007425 progressive decline Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
- C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
- C08G59/20—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the epoxy compounds used
- C08G59/22—Di-epoxy compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
- C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
- C08G59/20—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the epoxy compounds used
- C08G59/22—Di-epoxy compounds
- C08G59/26—Di-epoxy compounds heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
- C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
- C08G59/20—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the epoxy compounds used
- C08G59/32—Epoxy compounds containing three or more epoxy groups
- C08G59/3236—Heterocylic compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
- C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
- C08G59/40—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
- C08G59/50—Amines
- C08G59/504—Amines containing an atom other than nitrogen belonging to the amine group, carbon and hydrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L63/00—Compositions of epoxy resins; Compositions of derivatives of epoxy resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2363/00—Characterised by the use of epoxy resins; Derivatives of epoxy resins
Definitions
- the present invention relates to a hydrogel and more particularly to a water-based hydrogel, and to the reaction product of water-soluble monomeric or polymeric isosorbide epoxide and water-soluble amine, its method of preparation and its use.
- Hydrogels are a class of products which consist of a reversible physical or irreversible chemical network in which water can be trapped. These hydrogels are insoluble in water. Hydrogels are highly absorbent polymeric materials and are used in a variety of applications.
- polymer hydrogels in the literature contain polyester, polyurethane or silicone groups.
- Epoxies have been little studied in the manufacture of gels and even less in the manufacture of hydrogels. However, this involves simple and quantitative reactions at low temperatures. In addition, it is very insensitive to the presence of water, oxygen or impurities. Epoxies also exhibit excellent mechanical and thermal properties. Many epoxies and amines are available, but very few are soluble in water.
- WO2008079440A2 describes a process for preparing a superelastic epoxy-based hydrogel by reaction between polyetheramine and a polyglycidyl ether.
- hydrogels are their poor mechanical properties.
- the proportion of rigid monomer or the degree of crosslinking can be increased.
- the material becomes more fragile and has a reduced absorption capacity.
- hydrogels prepared from epoxy polymer of natural and non-fossil origin having improved mechanical properties while being easy to obtain and retaining facilitated water absorption.
- hydrogel based on polymers of natural and non-fossil origin such as isosorbide epoxide polymers or monomers, exhibited such characteristics.
- the rigid bicyclic structure of the isosorbide epoxide makes it possible to improve the mechanical properties of the hydrogels which are prepared with these polymers or monomers of isosorbide epoxide, while keeping very good characteristics. absorption of water thanks to the hydrophilic nature of these compounds.
- thermoset epoxy polymers and, more specifically, thermoset polymers obtained from renewable resources.
- a first object of the present invention relates to a water-based hydrogel, and to the reaction product of isosorbide epoxide monomer or water-soluble polymer and water-soluble amine chosen from a di-, tri-, or polyamine water soluble.
- a second object of the present invention relates to a process for preparing a hydrogel according to the invention comprising the following steps:
- a final object of the present invention relates to the use of the hydrogel according to the invention in the medical, cosmetic, agricultural, optical field, in the field of water treatment, hygiene products, in separation technology or in energy.
- water-based hydrogel and the reaction product of water-soluble monomeric or polymeric isosorbide epoxide and water-soluble amine selected from a water-soluble di-, tri-, or polyamine.
- water-based hydrogel is meant a material consisting of a three-dimensional network obtained by crosslinking of polymer chains in which water or an oil-in-water emulsion can be trapped.
- the three-dimensional cross-linked network, which is insoluble, is referred to in the following as the matrix of the hydrogel.
- the hydrogel matrix is composed of monomeric or polymeric isosorbide epoxide having the following formula (I): formula (I) [0022] where n is an integer from 0 to 300, in particular from 0 to 10, and more particularly from 0 to 5.
- the epoxide according to formula (I) can be manufactured according to the process described in application WO 2015/110758 A1.
- Isosorbide epoxide can be a mixture of different isosorbide epoxides which differ from each other by the R substituent and / or the n index.
- the index n can range from 0 to 300, in particular be equal to 290, 280, 270, 260, 250, 240, 230, 220, 210, 200, 190, 180, 170, 160, 150, 140 , 130, 120, 110, 100, 90, 80, 70, 60, 50, 40, 30, 20, 10, 9, 8, 7, 6, 5, 4, 3, 2, 1.
- the index n can be between 0 and 290, 0 and 280, 0 and 270, 0 and 260, 0 and 250, 0 and 240, 0 and 230, 0 and 220, 0 and 210, 0 and 200, 0 and 190, 0 and 180, 0 and 170, 0 and 160, 0 and 150, 0 and 140, 0 and 130, 0 and 120, 0 and 110, 0 and 100, 0 and 90, 0 and 80, 0 and 70, 0 and 60, 0 and 50, 0 and 40, 0 and 30, 0 and 20, 0 and 10, 0 and 9, 0 and 8, 0 and 7, 0 and 6, 0 and 5.
- the index n can be between 1 and 290, 1 and 280, 1 and 270, 1 and 260, 1 and 250, 1 and 240, 1 and 230, 1 and 220, 1 and 210, 1 and 200,
- the index n can be between 2 and 290, 2 and 280, 2 and 270, 2 and 260, 2 and 250, 2 and 240, 2 and 230, 2 and 220, 2 and 210, 2 and 200,
- the index n can be between 3 and 290, 3 and 280, 3 and 270, 3 and 260, 3 and 250, 3 and 240, 3 and 230, 3 and 220, 3 and 210, 3 and 200,
- the index n can be between 4 and 290, 4 and 280, 4 and 270, 4 and 260, 4 and 250, 4 and 240, 4 and 230, 4 and 220, 4 and 210, 4 and 200,
- the index n can be between 5 and 290, 5 and 280, 5 and 270, 5 and 260, 5 and 250, 5 and 240, 5 and 230, 5 and 220, 5 and 210, 5 and 200,
- the index n can be between 10 and 290, 10 and 280, 10 and 270, 10 and 260, 10 and 250, 10 and 240, 10 and 230, 10 and 220, 10 and 210, 10 and 200, 10 and 190, 10 and 180, 10 and 170, 10 and 160, 10 and 150, 10 and 140, 10 and 130, 10 and 120, 10 and 110, 10 and 100, 10 and 90, 10 and 80, 10 and 70, 10 and 60, 10 and 50, 10 and 40, 10 and 30, 10 and 20.
- the monomeric or polymeric isosorbide epoxide of formula (I) is crosslinked using a crosslinking agent.
- the crosslinking agent is a water soluble amine selected from a water soluble di-, tri-, or polyamine.
- the water-soluble amine is chosen from amino acids such as lysine, arginine, asparagine, glutamine, isophorone diamine, diaminodiphenylsulfone, hexamethylene diamine, m-xylendiamine and polyetheramines such as diaminopolypropylene glycol (Jeffamine® D-230) and trimethylolpropane poly (oxypropylene) triamine (Jeffamine® T-403) as well as mixtures thereof.
- amino acids such as lysine, arginine, asparagine, glutamine, isophorone diamine, diaminodiphenylsulfone, hexamethylene diamine, m-xylendiamine and polyetheramines such as diaminopolypropylene glycol (Jeffamine® D-230) and trimethylolpropane poly (oxypropylene) triamine (Jeffamine® T-403) as well as mixtures thereof.
- the ratio of epoxide equivalent of isosorbide monomer or water-soluble polymer to the number of NH functions of the water-soluble amine is between 1: 5 and 5: 1, preferably between 1: 2 and 2: 1 and more preferably 1: 1, the optimum ratio lying between 2: 1 and 1: 2 with a maximum density for a ratio of 1: 1.
- water demineralized water.
- the hydrogel has a degree of hydration of 50 to 99%.
- the hydration level is measured using the TGA: TG209F1 iris device from NETZSCH, according to the following method:
- a few mg of product are placed in an alumina crucible.
- a heating ramp is carried out from 25 ° C. to 300 ° C. at 10 ° C./min under inert gas (nitrogen with a flow rate of 40 ml / min).
- the hydrogel When the hydrogel is in the presence of a stimulus to which it is sensitive, it swells or contracts. Mention may be made, as type of stimulus, of pH, temperature, enzymes or other biochemical agents. It can also swell or shrink over time, depending on the environment in which it is found.
- the hydrogel according to the invention has the following properties:
- the mechanical properties and the crosslinking density of the hydrogel can be adjusted during the preparation process of the hydrogel.
- the hydrogels can have different physical forms, such as for example:
- the hydrogel is biocompatible.
- the hydrogel further comprises an active. All the characteristics of the hydrogel described above also apply to the hydrogel comprising an active.
- active is meant any body, material, or substance, pure or as a mixture, of a chemical, biochemical or living nature, having a technical effect or function, in a field of industry, in particular medical, cosmetic, agricultural, optical, in the field of water treatment, hygiene products, in separation technology or in energy etc.
- the active ingredient can be a pharmaceutical active principle which would be released under certain conditions.
- the active ingredient can be a skin tightening molecule.
- the active agent can be a molecule released on the surface of the eye when wearing a contact lens.
- the active ingredient can be a decontaminant.
- the active ingredient can be a decontaminant.
- the active ingredient When the hydrogel is water-based, the active ingredient is dissolved in water. The solution is then captured by the meshes of the network and is finally released by syneresis.
- the hydrogel When the hydrogel is based on an oil-in-water emulsion, the active ingredient is dissolved in the oily, discontinuous phase, emulsion. The emulsion is then captured by the meshes of the network and is finally released by syneresis.
- the active agent is a water-soluble active agent, preferably an odorous molecule, a cosmetic active agent or a water-soluble pharmaceutical active agent. This active agent can for example be isosorbide which is known for these healing properties.
- the hydrogel does not include an active ingredient, it makes it possible to subtract solid or particulate elements from a liquid medium containing this hydrogel.
- This hydrogel has utility in the medical, cosmetic, agricultural, optical fields, in the field of water treatment, hygiene products, in separation technology or in energy.
- the hydrogel can remove toxic molecules present in the human body.
- the hydrogel can remove unwanted molecules present on the surface of the skin.
- hydrogel can remove active ingredients from wastewater.
- the hydrogel can subtract the surfaces of an unwanted molecule.
- the hydrogel can subtract the molecule from a solution that one wishes to purify.
- measuring solid or particulate elements from a liquid medium containing this hydrogel means the act of trapping, or capturing, elements present in a liquid medium and then removing them from said medium.
- hydrogel in the medical, cosmetic, agricultural, optical field, in the field of water treatment, hygiene products, in separation technology or in energy.
- the process for preparing a hydrogel according to the invention comprises the following steps:
- an active is included in the hydrogel then it is prepared as above but adding the active during step 2) described above.
- steps 1) and 2) of the process for preparing the hydrogel according to the invention can be carried out successively in this order or vice versa or simultaneously.
- FIG. 1 is a diagram showing the kinetics of the concentration of isosorbide released into water from the preparation of Example 2.
- Isosorbide epoxide Arugula.
- Lysine Ajinomoto.
- Isosorbide as an active ingredient Arugula.
- Example 1 preparation of a hvdroael at 50% by mass of water
- Example 2 preparation of a hvdroael at 50% by mass of water further comprising isosorbide as active ingredient
- Example 3 relaraaae test of the preparation of Example 2
- the hydrogel containing the isosorbide obtained according to Example 2 is then immersed in a given volume of water.
- the released isosorbide content is determined by gas chromatography in the form of trimethylsilyl derivatives and quantified by the internal calibration method as described below
- the hydrogel according to the invention obtained by a simple preparation process, is a good alternative to hydrogels based on a polymer of fossil origin.
- the latter exhibits good water absorption, allowing the active ingredient it contains to be advantageously released. Because of these properties, the hydrogel according to the invention can therefore be used in various applications, in particular in the medical, cosmetic, agricultural, optical fields, water treatment, hygiene products, in technology. of separation or in energy.
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1913342A FR3103380B1 (en) | 2019-11-27 | 2019-11-27 | Hydrogel based on water, and the reaction product of isosorbide epoxide and amines |
PCT/FR2020/052182 WO2021105619A1 (en) | 2019-11-27 | 2020-11-26 | Water-based hydrogel, and reaction product of isosorbide epoxide and amines |
Publications (1)
Publication Number | Publication Date |
---|---|
EP4065624A1 true EP4065624A1 (en) | 2022-10-05 |
Family
ID=69630500
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20824305.5A Pending EP4065624A1 (en) | 2019-11-27 | 2020-11-26 | Water-based hydrogel, and reaction product of isosorbide epoxide and amines |
Country Status (6)
Country | Link |
---|---|
US (1) | US20220403118A1 (en) |
EP (1) | EP4065624A1 (en) |
JP (1) | JP2023503358A (en) |
KR (1) | KR20220108774A (en) |
FR (1) | FR3103380B1 (en) |
WO (1) | WO2021105619A1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7619056B2 (en) * | 2006-06-02 | 2009-11-17 | New Jersey Institute Of Technology | Thermoset epoxy polymers from renewable resources |
JP2009543902A (en) | 2006-07-10 | 2009-12-10 | メディパックス インコーポレイテッド | Superelastic epoxy hydrogel |
WO2013058778A1 (en) * | 2010-11-01 | 2013-04-25 | Nanoderm Sciences, Inc. | Polymers and hydrogels |
CN106474051B (en) * | 2011-03-21 | 2022-07-08 | 博任达生化科技(上海)有限公司 | Reverse temperature-sensitive reversible hydrogel composition |
FR3016631B1 (en) | 2014-01-21 | 2016-03-04 | Roquette Freres | PROCESS FOR PRODUCING GLYCIDYL ETHERS OF ISOHEXIDES PRODUCED THUS OBTAINED AND THEIR USES |
US9605108B2 (en) * | 2014-04-24 | 2017-03-28 | New Jersey Institute Of Technology | Isosorbide-derived epoxy resins and methods of making same |
-
2019
- 2019-11-27 FR FR1913342A patent/FR3103380B1/en active Active
-
2020
- 2020-11-26 WO PCT/FR2020/052182 patent/WO2021105619A1/en unknown
- 2020-11-26 US US17/756,396 patent/US20220403118A1/en active Pending
- 2020-11-26 JP JP2022531071A patent/JP2023503358A/en active Pending
- 2020-11-26 EP EP20824305.5A patent/EP4065624A1/en active Pending
- 2020-11-26 KR KR1020227017831A patent/KR20220108774A/en active Search and Examination
Also Published As
Publication number | Publication date |
---|---|
WO2021105619A1 (en) | 2021-06-03 |
FR3103380A1 (en) | 2021-05-28 |
KR20220108774A (en) | 2022-08-03 |
US20220403118A1 (en) | 2022-12-22 |
FR3103380B1 (en) | 2022-08-12 |
JP2023503358A (en) | 2023-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101884772B1 (en) | Silicone compositions comprising a swollen silicone gel | |
JP5376543B2 (en) | Polyion dendrimer and hydrogel comprising the same | |
CA2276711C (en) | Antimicrobial polymers comprising quaternary ammonium groups, their use for making a material with antimicrobial properties and methods for preparing them | |
CN1426424A (en) | Compound comprising crosslinked polyrotaxane | |
FR2465235A1 (en) | CONTACT LENS PRODUCED FROM POLYSILOXANE POLYMERS AND POLYCYCLIC ACRYLIC OR METHACRYLIC ESTERS | |
FR2847166A1 (en) | DOSAGE FORM COMPRISING CLOSED TAMSULOSIN PAGS, METHOD FOR PREPARING THE SAME, AND USE THEREOF | |
EP0377370A1 (en) | Process for encapsulating particles by means of a thermoplastic silicon copolymer, and such particles | |
CH667008A5 (en) | PROCESS FOR THE TREATMENT OF PHARMACEUTICAL DOSAGE FORMS. | |
FR3066116A1 (en) | PROCESS FOR PREPARING BIODEGRADABLE CAPSULES AND CAPSULES OBTAINED | |
CA2596147A1 (en) | Copolyhydroxyalkylglutamines which are functionalised with hydrophobic groups and applications thereof, such as in therapeutics | |
EP2408718A1 (en) | Composition based on calcium hydroxide, method for the production thereof and use of same for treating water and mud | |
Yu et al. | Materials established for enantioselective release of chiral compounds | |
EP3600642A1 (en) | Method for preparing capsules with improved retention properties and capsules obtained therefrom | |
WO2021105619A1 (en) | Water-based hydrogel, and reaction product of isosorbide epoxide and amines | |
Blelloch et al. | Crystal engineering of molecular solids as temporary adhesives | |
EP0389386A1 (en) | Polyester-polysiloxane block copolymer degradable by hydrolysis | |
FR2940064A1 (en) | ANTI-TRANSPARENT AGENT COMPRISING COMPONENTS CAPABLE OF FORMING COVALENT BONDS BETWEEN THEM AND METHOD OF TREATING HUMAN TWO STEP TRANSPIRATION | |
EP0043317B1 (en) | Process for the preparation of a polymer of the cross-linked polyurethane type having a tridimensional structure, product obtained by this process and its use as a swelling agent, especially therapeutically | |
FR3059665B1 (en) | PROCESS FOR THE PREPARATION OF MICROCAPSULES AND MICROPARTICLES OF CONTROLLED SIZE | |
EP1487569B1 (en) | Process for making biocompatible composite capsules | |
Johnson et al. | Microfluidics assisted fabrication of microspheres by poly (2–hydroxyethyl methacrylate)-block-poly (l-histidine) hybrid materials and their utilization as potential drug encapsulants | |
CA2583783C (en) | Complex containing mequitazine, a cyclodextrin and an interaction agent | |
WO2005051428A2 (en) | Method for obtaining a thermoreversible gel with a controlled three-dimensional structure, and gel obtained | |
US9221994B2 (en) | Aqueous based process to fabricate nanostructured block copolymer films | |
FR3132431A1 (en) | COSMETIC GEL COMPOSITION COMPRISING PARTICLES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20220603 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20231213 |